| Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply M Bonn, A Palayew, S Bartlett, TD Brothers, N Touesnard, M Tyndall Journal of studies on alcohol and drugs 81 (5), 556-560, 2020 | 126 | 2020 |
| The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals SR Bartlett, A Yu, N Chapinal, C Rossi, Z Butt, S Wong, M Darvishian, ... Liver International 39 (12), 2261-2272, 2019 | 83 | 2019 |
| Moving towards hepatitis C microelimination among people living with human immunodeficiency virus in Australia: the CEASE study M Martinello, J Yee, SR Bartlett, P Read, D Baker, JJ Post, R Finlayson, ... Clinical Infectious Diseases 71 (6), 1502-1510, 2020 | 70* | 2020 |
| The influence of hepatitis C virus genetic region on phylogenetic clustering analysis FMJ Lamoury, B Jacka, S Bartlett, RA Bull, A Wong, J Amin, J Schinkel, ... PloS one 10 (7), e0131437, 2015 | 70 | 2015 |
| Demonstration of near-elimination of hepatitis C virus among a prison population: the Lotus Glen Correctional Centre hepatitis C treatment project SR Bartlett, P Fox, H Cabatingan, A Jaros, C Gorton, R Lewis, E Priscott, ... Clinical Infectious Diseases 67 (3), 460-463, 2018 | 69 | 2018 |
| Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐and post‐universal access to direct‐acting antiviral treatment in … S Bajis, J Grebely, B Hajarizadeh, T Applegate, AD Marshall, ... Journal of viral hepatitis 27 (3), 281-293, 2020 | 49 | 2020 |
| Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study NZ Janjua, S Wong, Y Abdia, D Jeong, T Buller-Taylor, PA Adu, H Samji, ... Journal of Hepatology 75 (5), 1049-1057, 2021 | 48 | 2021 |
| Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review SR Bartlett, J Grebely, AA Eltahla, JD Reeves, AYM Howe, V Miller, ... Hepatology communications 1 (5), 379-390, 2017 | 41 | 2017 |
| Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis MT Yousafzai, S Bajis, M Alavi, J Grebely, GJ Dore, B Hajarizadeh Journal of viral hepatitis 28 (10), 1340-1354, 2021 | 33 | 2021 |
| Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison F Cholette, C Mesa, A Harris, H Ellis, K Cachero, P Lacap, Y Galipeau, ... PloS one 16 (12), e0261003, 2021 | 31 | 2021 |
| Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic hepatitis C in British Columbia, Canada: a population-based cohort study J Wilton, S Wong, A Yu, A Ramji, D Cook, ZA Butt, M Alvarez, M Binka, ... Open Forum Infectious Diseases 7 (3), ofaa055, 2020 | 31 | 2020 |
| A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies SR Bartlett, JO Wertheim, RA Bull, GV Matthews, FMJ Lamoury, ... Journal of viral hepatitis 24 (5), 404-411, 2017 | 30 | 2017 |
| Loss to follow‐up: a significant barrier in the treatment cascade with direct‐acting therapies M Darvishian, S Wong, M Binka, A Yu, A Ramji, EM Yoshida, J Wong, ... Journal of viral hepatitis 27 (3), 243-260, 2020 | 29 | 2020 |
| Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations C Rossi, D Jeong, S Wong, G McKee, ZA Butt, J Buxton, J Wong, ... Journal of hepatology 71 (6), 1116-1125, 2019 | 29* | 2019 |
| HCV reinfection rates after cure or spontaneous clearance among HIV‐infected and uninfected men who have sex with men PA Adu, C Rossi, M Binka, S Wong, J Wilton, J Wong, ZA Butt, S Bartlett, ... Liver International 41 (3), 482-493, 2021 | 25 | 2021 |
| It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison BL Harney, M Korchinski, P Young, M Scow, K Jack, P Linsley, C Bodkin, ... International Journal of Drug Policy 99, 103455, 2022 | 17 | 2022 |
| HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection SR Bartlett, B Jacka, RA Bull, F Luciani, GV Matthews, FMJ Lamoury, ... Infection, Genetics and Evolution 37, 252-258, 2016 | 17 | 2016 |
| Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct‐Acting Antiviral Era SR Bartlett, J Buxton, A Palayew, CA Picchio, NZ Janjua, N Kronfli Clinical Liver Disease 17 (2), 75-80, 2021 | 16 | 2021 |
| “The times they are a-changin’”: addressing common misconceptions about the role of safe supply in North America’s overdose crisis M Bonn, A Palayew, S Bartlett, TD Brothers, N Touesnard, M Tyndall Journal of studies on alcohol and drugs 82 (1), 158-160, 2021 | 15 | 2021 |
| Performance of immunoglobulin G serology on finger prick capillary dried blood spot samples to detect a SARS-CoV-2 antibody response AM Nikiforuk, B McMillan, SR Bartlett, AC Márquez, T Pidduck, J Kustra, ... Microbiology Spectrum 10 (2), e01405-21, 2022 | 13* | 2022 |
Naveed Zafar JanjuaBritish Columbia Centre for Disease Control & University of British ColumbiaVerified email at bccdc.ca
